Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SLPI Antikörper (Center)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch SLPI in WB und EIA. Es zeigt Reaktivität gegenüber Proben von Maus.
Produktnummer ABIN500776
864,62 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für SLPI Antikörper (Center) (ABIN500776)

Target

Alle SLPI Antikörper anzeigen
SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

Reaktivität

  • 51
  • 12
  • 2
Maus

Wirt

  • 44
  • 12
  • 3
Kaninchen

Klonalität

  • 48
  • 11
Polyklonal

Konjugat

  • 33
  • 9
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SLPI Antikörper ist unkonjugiert

Applikation

  • 47
  • 22
  • 22
  • 11
  • 11
  • 7
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 8
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Center

    Spezifität

    This antibody detects Antileukoproteinase (ALP).

    Kreuzreaktivität (Details)

    Species reactivity (tested):Mouse

    Aufreinigung

    Peptide affinity chromatography

    Immunogen

    SLPI antibody was raised against a 17 amino acid peptide from near the center of mouse SLPI.

    Isotyp

    IgG
  • Applikationshinweise

    ELISA. Western blot: 2 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS containing 0.02 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
  • Target

    SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))

    Andere Bezeichnung

    Antileukoproteinase (ALP)

    Hintergrund

    Secretory leukocyte protease inhibitor (SLPI) is produced at mucosal surfaces, primarily the upper respiratory tract and is thought to play an important role in the antiprotease defense mechanism of the lung. SLPI forms inhibitory complexes with numerous proteolytic enzymes such as neutrophil elastase, and has been shown to possess anti-inflammatory, anti-viral, and antibacterial activities. Its expression in oral epithelial cells is stimulated by HIV-1 gp120, suggesting that SLPI is a component of the oral mucosal response to HIV-1. In peripheral blood monocytes, SLPI can inhibit NF-kB activation by inhibiting IkB degradation in the cytoplasm and competing for NF-kB binding sites in the nucleus. This attenuation of the inflammatory response may also act to suppress liver metastases and other cancer cell invasions, but promote blood-borne metastasis via an invasion-independent pathway.Synonyms: BLPI, HUSI-1, Mucus proteinase inhibitor, Protease inhibitor WAP4, SLPI, Secretory leukocyte protease inhibitor, Seminal proteinase inhibitor, WAP four-disulfide core domain protein 4, WAP4, WFDC4

    Gen-ID

    20568

    NCBI Accession

    NP_035544

    UniProt

    P97430
Sie sind hier:
Chat with us!